Literature DB >> 16009137

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system.

Sarkis K Mazmanian1, Cui Hua Liu, Arthur O Tzianabos, Dennis L Kasper.   

Abstract

The mammalian gastrointestinal tract harbors a complex ecosystem consisting of countless bacteria in homeostasis with the host immune system. Shaped by evolution, this partnership has potential for symbiotic benefit. However, the identities of bacterial molecules mediating symbiosis remain undefined. Here we show that, during colonization of animals with the ubiquitous gut microorganism Bacteroides fragilis, a bacterial polysaccharide (PSA) directs the cellular and physical maturation of the developing immune system. Comparison with germ-free animals reveals that the immunomodulatory activities of PSA during B. fragilis colonization include correcting systemic T cell deficiencies and T(H)1/T(H)2 imbalances and directing lymphoid organogenesis. A PSA mutant of B. fragilis does not restore these immunologic functions. PSA presented by intestinal dendritic cells activates CD4+ T cells and elicits appropriate cytokine production. These findings provide a molecular basis for host-bacterial symbiosis and reveal the archetypal molecule of commensal bacteria that mediates development of the host immune system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009137     DOI: 10.1016/j.cell.2005.05.007

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  1036 in total

1.  Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells.

Authors:  Luisa Cervantes-Barragan; Jiani N Chai; Ma Diarey Tianero; Blanda Di Luccia; Philip P Ahern; Joseph Merriman; Victor S Cortez; Michael G Caparon; Mohamed S Donia; Susan Gilfillan; Marina Cella; Jeffrey I Gordon; Chyi-Song Hsieh; Marco Colonna
Journal:  Science       Date:  2017-08-03       Impact factor: 47.728

Review 2.  Innate immune signaling in defense against intestinal microbes.

Authors:  Melissa A Kinnebrew; Eric G Pamer
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 3.  The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.

Authors:  Neeraj K Surana; Dennis L Kasper
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 4.  Control of antiviral immunity by pattern recognition and the microbiome.

Authors:  Iris K Pang; Akiko Iwasaki
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

5.  Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria.

Authors:  Rawleigh Howe; Stephanie Dillon; Lisa Rogers; Martin McCarter; Caleb Kelly; Ricardo Gonzalez; Nancy Madinger; Cara C Wilson
Journal:  Clin Immunol       Date:  2009-01-25       Impact factor: 3.969

Review 6.  Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Raul Raz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 7.  Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration.

Authors:  Wenly Ruan; Melinda A Engevik; Jennifer K Spinler; James Versalovic
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

8.  Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.

Authors:  Mark W Musch; Yunwei Wang; Erika C Claud; Eugene B Chang
Journal:  Dig Dis Sci       Date:  2013-01-18       Impact factor: 3.199

9.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

10.  The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.